Lytix Biopharma AS (OSL:LYTIX)

Norway · Delayed Price · Currency is NOK

7.56

+0.30 (4.13%)

Sep 17, 2025, 12:35 PM CET

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Oncolytic Peptides	11.13M	Log In	Log In
Oncolytic Peptides Growth	178.98%	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	11.13M	Log In	Log In
United States Growth	178.98%	Log In	Log In
Norway	-	Log In	Log In